Loading...

Stephanie Murphy

TitleResearch Adm III
SchoolUCSF School of Medicine
DepartmentRadiology
Address185 Berry Street Bldg B
San Francisco CA 94158
Phone415-353-9446
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, BerkeleyBA Molecular and Cell Biology
    The Society of Clinical Research AssociatesCertified Clinical Research Professional (CCRP)2016

    Collapse Overview 
    Collapse Overview
    Stephanie Taylor Murphy is a Senior Clinical Research Coordinator in the UCSF Department of Radiology and Biomedical Imaging.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Schankin CJ, Maniyar FH, Seo Y, Kori S, Eller M, Chou DE, Blecha J, Murphy S, Hawkins RA, Sprenger T, VanBrocklin HF, Goadsby PJ. Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain. 2016 Jul; 139(Pt 7):1994-2001. PMID: 27234268.
      View in: PubMed
    2. LeBeau AM, Sevillano N, Markham K, Winter MB, Murphy S, Hostetter DR, West J, Lowman H, Craik CS, VanBrocklin HF. Imaging active urokinase plasminogen activator in prostate cancer. Cancer Res. 2015 Apr 1; 75(7):1225-35. PMID: 25672980; PMCID: PMC4383704 [Available on 04/01/16].
    3. LeBeau AM, Sevillano N, King ML, Duriseti S, Murphy S, Craik CS, Murphy LL, VanBrocklin HF. Imaging the urokinase plasminongen activator receptor in preclinical breast cancer models of acquired drug resistance. Theranostics. 2014; 4(3):267-79. PMID: 24505235; PMCID: PMC3915090.
    4. Hernandez AM, Huber JS, Murphy S, Janabi M, Zeng GL, Brennan KM, O'Neil JP, Seo Y, Gullberg GT. Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging. J Nucl Med. 2013 Nov; 54(11):1938-45. PMID: 24092939; PMCID: PMC4000452.
    5. LeBeau AM, Duriseti S, Murphy S, Pepin F, Hann B, Gray JW, VanBrocklin HF, Craik CS. Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer. Cancer Res. 2013 Apr 1; 73(7):2070-81. PMID: 23400595; PMCID: PMC3618559.
    6. Farkas ME, Aanei IL, Behrens CR, Tong GJ, Murphy S, O'Neil JP, Francis MB. PET Imaging and biodistribution of chemically modified bacteriophage MS2. Mol Pharm. 2013 Jan 7; 10(1):69-76. PMID: 23214968.
      View in: PubMed
    7. LeBeau AM, Lee M, Murphy S, Hann BC, Warren RS, Delos Santos R, Kurhanewicz J, Hanash SM, VanBrocklin HF, Craik CS. Imaging a functional tumorigenic biomarker in the transformed epithelium. Proc Natl Acad Sci U S A. 2013 Jan 2; 110(1):93-8. PMID: 23248318; PMCID: PMC3538269.
    8. Seo Y, Gustafson WC, Dannoon SF, Nekritz EA, Lee CL, Murphy S, VanBrocklin HF, Hernandez-Pampaloni M, Haas-Kogan DA, Weiss WA, Matthay KK. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model. Mol Imaging Biol. 2012 Dec; 14(6):735-42. PMID: 22382618; PMCID: PMC3369020.
    Back to TOP